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Lipocalin-2 regulates adult neurogenesis and contextual
discriminative behaviours
AC Ferreira1,2, T Santos3, B Sampaio-Marques1,2, A Novais1,2, SD Mesquita1,2, P Ludovico1,2, L Bernardino3, M Correia-Neves1,2,
N Sousa1,2, JA Palha1,2, JC Sousa1,2 and F Marques1,2
In the adult mammalian brain, newborn granule cells are continuously integrated into hippocampal circuits, and the ﬁne-tuning of
this process is important for hippocampal function. Thus, the identiﬁcation of factors that control adult neural stem cells (NSCs)
maintenance, differentiation and integration is essential. Here we show that the deletion of the iron trafﬁcking protein lipocalin-2
(LCN2) induces deﬁcits in NSCs proliferation and commitment, with impact on the hippocampal-dependent contextual fear
discriminative task. Mice deﬁcient in LCN2 present an increase in the NSCs population, as a consequence of a G0/G1 cell cycle arrest
induced by increased endogenous oxidative stress. Of notice, supplementation with the iron-chelating agent deferoxamine rescues
NSCs oxidative stress, promotes cell cycle progression and improves contextual fear conditioning. LCN2 is, therefore, a novel key
modulator of neurogenesis that, through iron, controls NSCs cell cycle progression and death, self-renewal, proliferation and
differentiation and, ultimately, hippocampal function.
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INTRODUCTION
In the adult mammalian brain, at the subgranular zone (SGZ) of
the dentate gyrus (DG) in the hippocampus,1 resident neural
progenitor cells give rise to new functional neurons that integrate
into the pre-existing neuronal circuitry, and modulate local neural
plasticity and network.1,2 This integration is important for
hippocampal integrity and function, such as the regulation of
learning, memory and pattern separation,3–5 emotion6 and
neurodegeneration.7 As so, understanding the factors that control
adult neural stem cells (NSCs) maintenance, differentiation and
integration is critical.
Of interest, iron is necessary for cell growth and differentiation8,9
and its acquisition by cells is essential for cell survival and maturation.
Accordingly, several studies showed that iron controls cell cycle
progression10 or arrest,11 and cell death-related genes.12 On the
other hand, iron is also potentially toxic due to its participation in
redox reactions that lead to the formation of reactive oxygen species
(ROS), thus creating an oxidative stress environment.13 Noticeably,
increasing evidence implicates ROS in the regulation of long-term
potentiation (LTP) in hippocampal neurons,14 and in neuropsychiatric
pathologies and cognitive performances.15–17
Most mammalian cells acquire iron via receptor-mediated
endocytosis of iron-loaded transferrin.18 However, in recent years,
lipocalin-2 (LCN2) has emerged as an alternative mechanism of
physiological iron delivery and uptake.19–21 As a member of the
lipocalin family, the best described function for LCN2 concerns its
secretion in the innate immune response to infection, to limit iron
availability for bacterial growth.22 Additionally, LCN2 has the
ability to interact with iron through a mammalian catechol
complex19,23 and modulate iron cell content.21 The existence of a
ﬁne-tuned mediation of intracellular iron by LCN2 is still poorly
recognized, but in the context of the brain, the iron-binding
capability of LCN2 was shown to be important in the regulation of
hippocampal neuronal dendritic spine density and morphology,24
with impact on structural plasticity and function. In fact, Lcn2
deletion is associated with increased anxiety, depressive-like
behaviour, spatial reference memory impairments and decreased
LTP.25 Nevertheless, the contribution of LCN2 in the regulation of
cell proliferation, putatively through iron trafﬁcking and iron-
mediated oxidative stress has never been explored in the brain.
In this study, we addressed the role of LCN2 in the adult
mammalian brain cell genesis, and its relevance for NSCs
homeostasis maintenance, as well as for the integrity of
hippocampal plasticity and function.
MATERIAL AND METHODS
Animal experiments
Experiments were performed in 2-months old male mice lacking Lcn2
expression (LCN2-null) and the respective wild-type (Wt) littermate
controls, in a C57BL/6J background. All animal procedures were conducted
in accordance with EU Directive 2010/63/EU and were approved by the
Portuguese national authority for animal experimentation (ID: DGV9457).
Mice were intraperitoneally injected with 50 mg kg− 1 of BrdU (Sigma
Aldrich, St Louis, MO, USA) 24 h before they were killed (for fast
proliferation protocol), or twice a day for ﬁve consecutive days, followed
by a chase period of 28 days (for slow dividing cells analysis). To test the
effect of iron chelation in cell cycle regulation, mice were intraperitoneally
injected with 200 μM of deferoxamine (DFO; Sigma), along with BrdU, and
killed 24 h later. To assess the capacity of iron chelation in contextual
discrimination, mice were chronically treated with DFO (200 μM) by
intraperitoneally injection every other day for 28 days, and in the end
tested for contextual fear conditioning. Animals were also pharmacologi-
cally treated with the antioxidant agent N-acetylcysteine (Sigma) by
intraperitoneally injection with 300 mg kg− 1, and killed 24 h later. The
respective control groups were injected with saline.
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Immunohistochemistry and imaging
Brains were ﬁxed by transcardial perfusion with 4% paraformaldehyde,
sectioned in a cryostat and incubated overnight with primary antibodies,
followed by the respective ﬂuorescent secondary antibodies. Fluorescence
images were acquired with the Olympus Fluoview FV1000 confocal
microscope (Olympus, Hamburg, Germany) and the number of double-
positive cells calculated using Olympus Fluoview FV1000 software.
Contextual fear conditioning
Contextual fear conditioning was conducted for 2 days and each test
session was scored. On the conditioning day, mice were placed in a
chamber with a stainless grid ﬂoor and pairings between light and shock
(1 s, 0.5 mA) were delivered, spared from each other with an interval of
20 s (Figure 3a). On day 2, mice were re-exposed to the conditioning
chamber for 3 min for contextual fear memory and 2 h later presented to a
novel context, where the grid was removed, black plastic inserts covered
the ﬂoor and the walls of the chamber, which was also scented with a
paper towel dabbed with vanilla extract. The session consisted of a 3-min
trial and animal freezing was scored for the entire session and deﬁned as
the complete absence of motion for a minimum of 1 s.
NSCs culture
Stem cells were cultured from 1–3 days-old Wt and LCN2-null mice SGZ, as
an adaptation of the protocol described elsewhere.26 Parameters analysed
included cell proliferation, self-renewal, cell cycle, cellular viability and
death, and ROS levels. Cell treatments included the exposure of LCN2-null-
derived neurospheres to recombinant mouse LCN2 protein (R&D Systems,
Minneapolis, MN, USA), at a concentration of 100 ng ml− 1 for 24 or 72 h,
and to 2 μM of DFO for 24 h. Also, Wt cultures were treated with 500 μM of
ferric ammonium citrate (Sigma) for 24 h.
For a more detailed description of the experimental procedures, please
see Supplementary information.
Statistical analyses
All experiments were performed and analysed by the same experimenter,
blind to the animals’ genotype or group treatment under assessment.
Animals were assigned to groups according to their genotypes, and no
method of randomization was applied. Sample sizes were determined by
power analyses based on previously published studies.25 Variables
followed a Gaussian distribution as revealed by the D'Agostino and
Pearson normality test. Data are reported as mean± standard error (s.e.m.).
Statistical signiﬁcant differences between groups were determined using
two-tailed Student’s t-test for two comparisons, and two-way analysis of
variance, followed by Bonferroni’s multiple comparison test for multiple
comparisons. Values were considered to be statistically signiﬁcant for
P⩽ 0.05 (* or #), P⩽ 0.01 (** or ##), P⩽ 0.001 (*** or ###) and P⩽ 0.0001
(**** or ####). For the in vitro analysis, the number of independent
experiments is speciﬁed in the legend of each ﬁgure.
RESULTS
The absence of LCN2 leads to decreased rates of cell proliferation
In order to understand the role of LCN2 in the process of adult
neurogenesis, we ﬁrst analysed the rates of proliferating cells in
the SGZ of the DG in LCN2-null mice. For that, the number of cells
entering the S-phase was analysed by injecting animals once with
BrdU (Figure 1a) and 24 h later, quantiﬁcation of the total number
of BrdU+ cells showed a signiﬁcant reduction (P= 0.004) in LCN2-
null mice hippocampus when compared to Wt littermate controls
(Figures 1b and c).
Interestingly, when we analysed the levels of LCN2 mRNA, by
RT-PCR (not shown), and protein expression by western blot and
immunohistochemistry in the DG of adult mice, we were not able
to detect expression of LCN2 (Supplementary Figures S1a and b),
which is in accordance with other reports.27,28 Nevertheless,
analysis of protein expression revealed that LCN2 is highly present
in the serum (Supplementary Figure S1a), suggesting that a
possible regulation of adult neurogenesis by LCN2 may occur
extrinsically to the brain, through its delivery by the blood vessels
that surrounds the neurogenic niches, which needs further
clariﬁcation.
The subsequent analysis of the endogenous Ki67 marker of
proliferation revealed that LCN2-null mice also presented a
signiﬁcant reduction (P= 0.012) in the number of Ki67+ cells
(Figures 1b and c). Also, the effect of LCN2’s absence on cell
proliferation at the adult subventricular zone (SVZ) was studied
and, similarly, LCN2’ absence impaired cell proliferation
(Supplementary Figures S2a–c).
LCN2-null mice present deﬁcits in adult progenitors differentiation
The impact of LCN2 in the generation of newborn mature cells in
the neurogenic niches was next investigated. Twenty-four hours
upon BrdU injection, quantiﬁcation of the number of proliferating
neuroblasts (DCX+ BrdU+ cells; Figure 1d) revealed a signiﬁcant
reduction (P= 0.01) in the SGZ of LCN2-null mice (Figures 1e
and h). Concomitantly, analysis of newborn neurons (Calb+ BrdU+
cells; P= 0.05) and of new mature astrocytes (S100β+ BrdU+
cells; P= 0.04; Figures 1f–h), showed signiﬁcant decrease in LCN2-
null mice. Similarly, the analysis of the DCX+ BrdU+ neuronal
precursor cells, in LCN2-null mice SVZ, revealed a signiﬁcant
decrease (Supplementary Figures S3a–c). Nevertheless, the
proportion of 28-days old newborn neurons that migrated into
the olfactory bulb was similar between animals (Supplementary
Figures S3d–f).
The absence of LCN2 impairs NSCs proliferation and survival
Since LCN2’s absence affected progenitors proliferation and
differentiation, we next analysed if such impairments were
dependent on the misregulation at the level of the stem cells
pool. Firstly, we identiﬁed radial glia-like type-1 stem cells, as
GFAP+ BrdU+ cells (Figure 1d), and observed a marked increase
(P= 0.009) in LCN2-null mice SGZ (Figures 1i and l). Consistently,
for the SVZ, an increase in type-B1 stem cells was observed
(Supplementary Figures S4a and b). Moreover, the transcription
factor Sox2 was used to identify nonradial type-1 stem cells
(Sox2+ Ki67−; Figure 1d) and type-2 amplifying progenitor cells
(Sox2+ Ki67+). Even though the total number of Sox2+ cells in the
SGZ of LCN2-null mice was similar to the number observed in Wt
littermate controls (Supplementary Figure S5e), analysis of the
nonradial type-1 stem cells conﬁrmed that LCN2’ absence leads to
a signiﬁcant (P= 0.04) increase in this population (Figures 1j and l).
On the other hand, quantiﬁcation of type-2 stem cells (Sox2+
Ki67+) revealed a prominent decrease (P= 0.04) in LCN2-null mice
SGZ (Figures 1k and l).
Overall, and despite the total number of cells being similar, a
consistent increase in quiescent type-1 stem cells (radial and
nonradial types) and a prominent depletion of type-2 amplifying
progenitor cells was evident in the SGZ of LCN2-null mice, which
suggests the existence of a misregulation in cell transition from
type-1 to type-2 progenitors when LCN2 is absent, with
subsequent impact on neuronal and glial lineages.
LCN2 deletion affects progenitors cycling, promoting cell cycle
exit and death
Data presented suggested the requirement of LCN2 for the
speciﬁc regulation of the NSCs pool maintenance and differentia-
tion, which next lead us to analyse the cell cycle regulation in
LCN2-null mice SGZ. The number of cells exiting and re-entering
the cell cycle at the SGZ within 24 h after the BrdU pulse
were indexed (Figure 2a) and revealed that the proportion of cell
cycle exit was signiﬁcantly increased (P= 0.003) in LCN2-null mice;
in contrast, a signiﬁcant lower proportion of cells were observed
to re-entry the cycle (P= 0.03; Figures 2b, c and e). Interestingly, a
similar regulation of the cell cycle at the SVZ was observed
(Supplementary Figures S4a–c).
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This increased cell cycle exit in LCN2-null DG could, at least in
part, explain the observed decrease in the number of dividing
progenitors and, consequently, of newborn mature cells; however,
it did not clarify which cells exit the cycle. Quantiﬁcation of the
percentage of Sox2+ cells in cycle showed a clear decrease
(P= 0.002; Figures 2d and e) when LCN2 was absent, further
supporting the idea that LCN2 regulates cell cycle in type-1 stem
cells and the transition to type-2 in the DG. Also, LCN2-null mice
Figure 1. LCN2-null mice present reduced rates of cell proliferation and impaired NSCs proliferation, survival and maturation in the adult
hippocampus. (a) Schematic diagram of the SGZ of the DG at the hippocampus and of the BrdU protocol used. (b) Quantiﬁcation analysis of
BrdU+ and Ki67+ cells in the SGZ (n= 5 per group). (c) Representative images of BrdU and Ki67 immunostaining at SGZ (indicated by black
arrows; scale bar, 50 μM). (d) Schematic diagram of the experimental protocol of BrdU used and illustration of the hippocampal neurogenesis
process, including cellular types and their speciﬁc markers. (e–g) Reduction of DCX+ BrdU+ neuronal precursors, of newborn mature neurons
(Calb+ BrdU+) and astrocytes (S100β+ BrdU+) in LCN2-null SGZ, compared to Wt mice (n= 6 per group). (h) Confocal images of DCX/BrdU, Calb/
BrdU and S100β/BrdU co-labelling. (i,j) Increased number of radial glia-like GFAP+ BrdU+ type-1 stem cells and of nonradial Ki67− Sox2+ type-1
stem cells in LCN2-null mice (n= 5 per group). (k) Decreased number of Ki67+ Sox2+ type-2 progenitor cells in LCN2-null SGZ (n= 5 per group).
(l) Representative co-immunostaining of GFAP/BrdU and Ki67/Sox2 at DG (identiﬁed by black arrows; scale bars, 50 μM). Data are presented as
mean± SEM analysed by two-tailed Student’s t-test and are representative of two independent experiments. *P⩽ 0.05, **P⩽ 0.01. ANP,
amplifying neural progenitor; Calb, calbindin; DCX, doublecortin; DG, dentate gyrus; GCL, granular cell layer; IHC, immunohistochemistry;
LCN2, lipocalin-2; ML, molecular layer; NSC, neural stem cells; QNP, quiescent neural progenitor; SGZ, subgranular zone. See also
Supplementary Figures S2 and S3.
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displayed increased hippocampal cell death, as quantiﬁed by the
number of positive cells for activated caspase-3 (Casp3+)
(P= 0.048), and further co-immunostaining analysis revealed that
the number of radial type-1 stem cells expressing Casp3+ was
signiﬁcantly increased in LCN2-null mice (P= 0.03), when com-
pared to Wt (Supplementary Figures S5a–d).
As so, the data presented suggest that the impaired cell genesis in
the adult hippocampus in LCN2-null mice is the consequence of a
deﬁcient cell cycle regulation and of substantial apoptosis of type-1
NSCs. More importantly, this seems to be due to a lack of an
antioxidant regulation at the level of stem cells resultant
from the LCN2’s absence, since a signiﬁcant (P=0.009) decrease of
glutathione peroxidase-4 (Gpx4) expression by Sox2+ stem cells was
observed in LCN2-null mice (Supplementary Figures S5d and e).
LCN2-null mice impaired hippocampal neurogenesis affects
contextual discrimination behaviour
Consistent with the current knowledge that adult hippocampal
neurogenesis contributes to enhance the extent of information
encoded by the DG and improves pattern separation and
contextual discrimination, the ability of LCN2-null mice to
discriminate between overlapping contextual representations in
a contextual fear conditioning task was next investigated.
Assessment of animals’ behaviour during training revealed that
animals presented similar percentage of freezing (Block I-III;
Figure 3b). Upon re-exposure to the conditioning context, 24 h
after the training and with no cue presentation, LCN2-null mice
showed a signiﬁcant (P= 0.004) decreased percentage of freezing
(Figure 3c). Subsequent analysis of contextual discrimination, by
exposing the animals to a novel context 2 h later, revealed that
LCN2-null mice presented similar levels of freezing behaviour
when compared to the training context, while Wt mice presented
substantially less freezing behaviour upon exposure to the novel
context (Figure 3c). This altered behaviour translated into a lack of
context discrimination capacity by LCN2-null mice (discrimination
index: P= 0.002; Figures 3c and d). Overall, this reveals the
importance of the observed impaired adult hippocampal neuro-
genesis in LCN2-null mice, since it translated into deﬁcits in
hippocampal function.
The absence of LCN2 impairs in vitro neural stem cell proliferation
and self-expansion
In order to mechanistically understand how the absence of LCN2
affects hippocampal precursors’ proliferation and survival, with
Figure 2. LCN2 deletion impairs the number of cycling DG progenitors by favouring cell cycle exit. (a) Schematic representations of the BrdU
protocol, of the cell cycle phases that BrdU and Ki67 co-labelling correspond to and of the indexes used for cell cycle exit and re-entry. (b)
Increased proportion of cells exiting the cell cycle at the SGZ in the absence of LCN2 (n= 5 per group). (c) Reduced number of cells re-entering
the cell cycle in the SGZ of LCN2-null mice (n= 5 per group). (d) Decreased percentage of type-2 progenitor cells in cycle at the SGZ (n= 5 per
group) in the absence of LCN2. (e) Representative confocal immunostaining images of BrdU/Ki67 and Sox2/Ki67 co-labelling, indicated by
white arrows; scale bar, 100 μM. Data presented as mean± SEM analysed by two-tailed Student’s t-test and are representative of two
independent experiments. *P⩽ 0.05, **P⩽ 0.01. See also Supplementary Figure S4. DFO, deferoxamine; DG, dentate gyrus; IHC,
immunohistochemistry; LCN2, lipocalin-2; SGZ, subgranular zone.
Figure 3. Impaired contextual fear conditioning in LCN2-null mice. (a) Experimental scheme of the used paradigm for contextual fear
condition test. (b) Freezing behaviour during the training session, as total percentage of freezing and of freezing acquired along the trials of
shock exposure (Block I-III). (c) Impaired contextual retrieval by LCN2-null mice at context A, but similar freezing between genotypes at
context B (n= 10 per group). (d) Discrimination index is impaired in LCN2-null mice. Data are presented as mean± SEM analysed by two-tailed
Student’s t-test and are representative of two independent experiments. **P⩽ 0.01. LCN2, lipocalin-2.
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important consequences at the behavioural level, a further
detailed characterization was performed using in vitro culture
assays.
Analysis of BrdU+ cells [over total positive nuclei (DAPI+)]
revealed that LCN2-null-derived neurospheres presented a
signiﬁcant (P= 0.03) decrease in the percentage of proliferative
cells (Figures 4a and b). Moreover, the clonal neurosphere assay
showed that the total number of primary and secondary
neurospheres generated from LCN2-null NSCs were signiﬁcantly
lower when compared to Wt (Figures 4c and e). Similarly,
analysis of the mean size of the neurospheres revealed
that both primary (P= 0.03) and secondary neurospheres
(P= 0.03) obtained from LCN2-null SGZ were smaller (Figures
4d and e).
The effect of LCN2’s absence on the self-renewal of SGZ cells
was subsequently tested by adhering neurospheres for 48 h
under proliferative conditions, and further labelled for Sox2 and
BrdU. Quantiﬁcation of the percentage of Sox2+ BrdU+ cells
revealed a signiﬁcant decrease in LCN2-null-derived NSCs
(P= 0.03), thus conﬁrming a signiﬁcant effect on self-renewal
capabilities in NSCs from LCN2-null SGZ (Figures 4f and g). We
anticipated that LCN2 exerted such particular modulation
through its speciﬁc cellular receptor 24p3R.21 In fact, in vivo
analysis of 24p3R expression by immunoﬂuorescence at the
DG, in Wt animals, revealed that the receptor was present
throughout the gyrus and in the hilus (Supplementary
Figures S6a and a′). Speciﬁcally, additional co-labelling assess-
ments showed that NSCs positive for Sox2 and Nestin
(Supplementary Figures S6b and c) co-expressed 24p3R, as well
as labelled-retaining BrdU+ cells at the SGZ (Supplementary
Figure S6d). In addition, analysis of 24p3R expression in
cultured neurospheres revealed that NSCs under proliferative
conditions express the LCN2 receptor (Supplementary Figures
S6e and f).
LCN2 regulates NSCs endogenous levels of ROS, which is required
for a proper cell cycle progression
To assess the inﬂuence of LCN2 in neurospheres cell cycle
progression, the proportion of NSCs at the different cell cycle
phases were analysed by ﬂow cytometry. After labelling 7 days-old
cultured neurospheres with propidium iodide, the analysis of the
DNA content in each genotype revealed that the percentage of
cells at G0/G1 phase was signiﬁcantly (Po0.0001) higher in LCN2-
null cells (Figures 4h and i). In accordance, a signiﬁcant
(Po0.0001) decrease in the proportion of cells at S phase was
observed, as well as for the G2/M phase (P= 0.01; Figures 4h and i).
Interestingly, when LCN2-null neurospheres were treated with
exogenous recombinant LCN2 (rLCN2) for 24 and 72 h, we found
that 72 h of treatment signiﬁcantly (P= 0.02) decreased the
percentage of cells at G0/G1, when compared to LCN2-null
neurospheres alone, and that it allowed NSCs cell cycle progres-
sion, since it signiﬁcantly (P= 0.008) increased the percentage of
cells at S phase (Figures 4h and i). These observations did not,
however, provide information on how LCN2 determines the
control of NSCs cell cycle progression. In recent years, the
modulation of cellular redox states has been suggested to be
important for the balance between self-renewal and differentia-
tion in progenitor cells. Of notice, and consistent with the idea of
LCN2’ role in iron trafﬁcking,19,20 we further considered the
putative contribution of LCN2’s absence to a ROS-dependent
cell cycle arrest and death. In fact, analysis of intracellular
ROS levels in NSCs revealed a signiﬁcant (P= 0.03) increase in
LCN2-null-derived cells, which was successfully reverted by the
addition of rLCN2 for 72 h (Figure 4j). Moreover, we observed
that the overproduction of ROS in the absence of LCN2 sensitized
NSCs to cell death, which was demonstrated by the increase
in the percentage of non-viable cells in LCN2-null (P= 0.06;
Figures 4k and l) and of the percentage of apoptosis (Annexin
V+PI−; P= 0.002) (Figure 4m). Moreover, in vivo treatment of
Figure 4. LCN2 is required for NSCs G0/G1 cell cycle transition, through the control of endogenous redox cellular status, and its absence
impairs proliferation and self-renewal and promotes cell apoptosis. (a,b) Reduction of proliferating neurospheres represented by BrdU+ cells/
total cells in LCN2-null derived cells. (c) Reduction of the number of primary and secondary neurospheres in the absence of LCN2. (d) Average
diameter of primary and secondary neurospheres. (e) Cultured primary and secondary spheres from Wt and LCN2-null SGZ. (f,g) NSCs sphere-
renewal impaired in LCN2-null as quantiﬁed by Sox2+ BrdU+ cells. Scale bars, 100 μM. (h,i) Increased percentage of NSCs at G0/G1 phase of the
cell cycle in LCN2-null mice, rescued upon delivery of exogenous rLCN2 protein. (j) Two-fold increased levels of intracellular ROS in LCN2-null
derived neurospheres, restored upon rLCN2 treatment. (k,l) Live and dead assay by ﬂow cytometry. (m) Increased NSCs apoptosis in LCN2-null
mice. Data are presented as mean± SEM, analysed by two-tailed Student’s t-test and are representative of three independent experiments.
*P⩽ 0.05, **P⩽ 0.01, ****P⩽ 0.0001 for Wt vs LCN2-null; #P⩽ 0.05, ##P⩽ 0.01, ####P⩽ 0.0001 for treatment vs LCN2-null alone. rLCN2,
recombinant LCN2. LCN2, lipocalin-2; NSC, neural stem cells; ROS, reactive oxygen species; SGZ, subgranular zone.
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LCN2-null mice for 24 h with the antioxidant agent N-acetylcys-
teine (300 mg kg− 1)29 signiﬁcantly reduced (P= 0.02) the levels of
Casp3+ in the SGZ, when compared to the saline control group
(Supplementary Figure S5h), which suggests that ROS accumula-
tion in the absence of LCN2 is likely the inducer of the observed
increased cell death.
Oxidative damage induced by LCN2 absence is iron-mediated
Recognizing that excessive intracellular iron promotes oxidative
stress, the connection between iron regulation and ROS, by LCN2
and speciﬁcally in NSCs, was next studied. For that, NSCs
intracellular iron levels were depleted by adding the membrane-
permeable iron chelator DFO to LCN2-null neurospheres for 24 h
Figure 5. LCN2 absence imposed oxidative damage and cell cycle arrest is dependent on intracellular iron regulation. (a) Increased oxidative
damage of LCN2-null is rescued by DFO. (b,c) Cell cycle arrest in LCN2-null mice derived neurospheres is restored after DFO treatment. (d,e)
In vivo impaired cell cycle exit and re-entry in LCN2-null SGZ is normalized after the DFO treatment. (f) Representative confocal
immunostaining images of BrdU/Ki67 co-labelling. Indicated by white arrows; scale bar, 50 μM. (g) Impaired contextual retrieval by LCN2-null
mice at context A restored upon DFO chronic treatment (n= 6 per group). (h) Discrimination index is improved after DFO in LCN2-null mice. (i)
Proposed mechanism for the role of LCN2 in the control of NSCs cell cycle progression through intracellular iron regulation and ROS
signalling, for contextual discriminative behaviours. Data are presented as mean± SEM and are representative of two independent
experiments. (a,b) two-tailed Student’s t-test; *P⩽ 0.05, **P⩽ 0.01, ****P⩽ 0.0001, Wt vs LCN2-null; #P⩽ 0.05, ##P⩽ 0.01, ####P⩽ 0.0001,
treatment vs LCN2-null alone. (d,e,g,h) two-way analysis of variance analysis with Bonferroni’s multiple comparison test; *P⩽ 0.05 vs saline Wt;
#P⩽ 0.05, ###P⩽ 0.001 vs saline LCN2-null mice. DFO, deferoxamine; LCN2, lipocalin-2; NSC, neural stem cells; ROS, reactive oxygen species;
SGZ, subgranular zone.
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[2 μM;30]. Noticeably, relative to LCN2-null cultures alone, DFO
treatment signiﬁcantly (Po0.0001) reduced the intracellular levels
of ROS in neurospheres, to levels similar to those occurring in Wt
animals (Figure 5a). Additionally, cell cycle analysis in LCN2-null
neurospheres treated with DFO and labelled with propidium
iodide, revealed that DFO signiﬁcantly decreased the percentage
of cells arrested at G0/G1, when compared to LCN2-null neuro-
spheres alone (P= 0.004; Figures 5b and c), and allowed the
progression of NSCs in the cycle, since it increased the percentage
of cells at S (P= 0.09) and G2 (P= 0.02) phases.
These results suggest that intracellular iron accumulation in
NSCs, due to the absence of LCN2, is the key underlying
mechanism promoting oxidative stress and cell cycle arrest. In
fact, and interestingly, treatment of cultured Wt NSCs with an iron
source (ferric ammonium citrate) for 24 h [500 μM;31] similarly
induced a signiﬁcant (P= 0.02) increase in the production of ROS,
when compared to control non-treated cultures (Supplementary
Figure S7a). Importantly, this iron-mediated imposed oxidative
stress also induced cell cycle arrest, as ferric ammonium citrate
signiﬁcantly increased the proportion of cells at G0/G1 phase
(P= 0.007), not allowing for cells to progress in cycle (S phase:
P= 0.01; Supplementary Figures S7b and c), which largely
resembles the phenotype observed to occur in the absence
of LCN2.
Moreover, in vivo analysis of cell cycle indexes of exit and re-
entry, after DFO treatment for 24 h [200 μM;32], showed that iron
chelation was sufﬁcient to improve progenitors cell cycle
regulation in the SGZ of LCN2-null mice (treatment effect:
F1,13 = 19.3, Po0.0001). Speciﬁcally, DFO signiﬁcantly normalized
cell cycle exit in LCN2-null SGZ (P= 0.0005), promoting progenitors
cell cycle re-entry (P= 0.0007), to indexes similar to those
occurring in Wt animals (Figures 5d–f). In fact, a signiﬁcant
increase in cell proliferation was observed in LCN2-null mice DG
after treatment with DFO, of both BrdU+ (treatment effect:
F1,14 = 20.5, P= 0.0005) and Ki67
+ cells (treatment effect:
F1,15 = 10.9, P= 0.005; Supplementary Figures S7a and b), with an
additional prominent decrease (P= 0.03) in the number of Casp3+
cells in the SGZ of LCN2-null mice (Supplementary Figure S8c).
Importantly, the additional chronic administration of DFO for
28 days signiﬁcantly improved the performance of LCN2-null mice
in the contextual fear conditioning. The observed decreased
percentage of freezing presented by LCN2-null mice was
signiﬁcantly improved after DFO treatment (P= 0.02), when
compared to saline-treated LCN2-null animals (Figure 5g). More-
over, context discriminatory indexes were also recovered in LCN2-
null mice after DFO treatment (P= 0.08; Figure 5h).
DISCUSSION
This study provides in vivo and in vitro evidence for a novel role for
LCN2 as a modulator of neurogenesis in the adult mammalian
brain. It shows that, in vivo, LCN2 deletion induces deﬁcits in
neural progenitors proliferation, differentiation and maturation,
with impact on contextual discriminative behaviours. Speciﬁcally,
the absence of LCN2 leads to an accumulation of type-1 (radial
and nonradial) stem cells, due to a misregulation of the cell cycle,
with a higher proportion of progenitor cells exiting the cycle
towards apoptotic cell death. Moreover, NSCs cultured in vitro
allowed to mechanistically disclose that the deletion of LCN2
signiﬁcantly induces endogenous oxidative stress, cell cycle arrest
and death, an effect that is iron-mediated since it is restored by
the addition of the iron chelator DFO. Altogether, the data
presented imply that LCN2 is required to control NSCs redox
status, functioning as an antioxidant agent in the maintenance of
a proper oxidative environment for cell cycle progression and
stem cells’ self-renewal. This mechanism of cell cycle regulation is
crucial for hippocampal integrity and function, as the absence of
LCN2 impacts on contextual fear discriminative behaviours.
Iron is an essential element required by almost all organisms,
playing critical physiological roles that include oxygen transporta-
tion, energy metabolism and cellular proliferation. On the other
hand, iron is a highly reactive element, having a catalytic role in a
multitude of redox reactions.13 Iron homeostasis dysfunction is
the major source of oxidative stress via the generation of ROS by
the Fenton’s reaction and the aberrant cellular accumulation of
iron, ROS, or both, is linked to DNA damage, cell cycle arrest
and death.13 In recent years, LCN2, primarily considered to be
exclusively an innate immune protein, was shown to have multi-
faceted roles in cellular iron transport and homeostasis.19,21,23
Importantly, the isolation and identiﬁcation of 24p3R by
Devireddy and colleagues (2005) paved the way to propose the
existence of an iron delivery mechanism that is LCN2-mediated
and transferrin-independent.19,21 Speciﬁcally, it was proposed that
upon binding to 24p3R, iron-containing LCN2 is internalized,
trafﬁcs to the endosomes being iron released from LCN2, thereby
increasing intracellular iron.21 On the other hand, the binding and
internalization of iron-free LCN2 chelates intracellular iron and may
transfer it to the extracellular milieu, thus reducing intracellular
iron.21 In line with this, herein we propose LCN2 as an iron sequester
in NSCs, with impact on cell cycle regulation and cell death and,
ultimately, animal behaviour. Importantly, LCN2-mediated iron
delivery to NSCs is most likely occurring by its internalization
through the speciﬁc 24p3R, shown here to be present in neuro-
spheres and stem cells in vivo. In fact, previous studies in kidney cells
demonstrated the internalization of LCN2 and its localization in
vesicles scattered throughout the cytoplasm, and in distinct
intracellular compartments of that of internalized transferrin.19 This
is a mechanism that should be next further studied in the context of
NSCs. Still, altogether, it is increasingly clearer that LCN2 seems to
actively participate in cell physiology in several organs.
The regulation of NSCs physiology by LCN2 was primarily
observed by the loss of general proliferation rates in the absence
of LCN2, when using both BrdU and Ki67 proliferative markers.
Moreover, the absence of LCN2 was sufﬁcient to induce the
accumulation, expansion and apoptosis of type-1 stem cells (radial
and nonradial type of cells), with a subsequent reduction in the
proliferation of type-2 and of cell genesis commitment, matura-
tion and integration. Speciﬁcally, cell cycle transition from G1 to S
phase was compromised in LCN2-null mice, with NSCs being
arrested at G0/G1 phase and exiting more the cell cycle.
Mechanistically, the current observations support the notion that
the lack of LCN2 in NSCs leads to endogenous iron accumulation,
which in turn increases intracellular ROS, thus creating an
oxidative environment that is boosting cell cycle arrest and cell
death. Actually, the observation that treatment of LCN2-null mice
with the well-known antioxidant agent N-acetylcysteine29,33
decreases apoptotic cell death clearly indicates that ROS,
increased as the consequence of intracellular iron accumulation
by the absence of LCN2, is the likely inducer of cell death in the
DG of LCN2-null mice. This is a novel mechanism of NSC
commitment that, ultimately, impairs animal behaviour, as shown
here (Figure 5i). Consistent with the known ability of LCN2 to
trafﬁc iron within the cells, the in vitro reversion of the oxidative
environment and of cell cycle progression with DFO treatment,
along with the in vivo prevention of an exacerbated cell cycle exit
and apoptotic cell death at the SGZ, as well as the improvement in
the contextual behaviour, strengths such hypothesis. This ﬁnding
is novel as it shows that LCN2 acts in the regulation of
endogenous ROS levels in NSCs by controlling its cellular content.
Also, and since the addition of rLCN2 restores ROS levels and
promotes cell cycle progression, it is possible to assume that
this treatment, likewise, restores endogenous levels of iron in
LCN2-null neurospheres. Interestingly, and of notice, others have
shown that LCN2-null mice have increased intracellular34 and
serum32 iron levels, which renders them more susceptible to
lipopolysaccharide-mediated oxidative stress.32 In addition,
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DFO treatment in LCN2-null mice was effective in rescuing
lipopolysaccharide-induced toxicity, including the reduction of
cleaved caspase-3 levels.32 It is possible that, also in the brain and
speciﬁcally in the neurogenic niches, LCN2-null mice accumulate
iron in neural progenitors, which is impacting on ROS levels, and
on the normal progress of cell cycle and adult neurogenesis
sequence. Importantly, the fact that the addition of iron to Wt
NSCs induced oxidative stress and cell cycle arrest, thus
mimetizing the impairments observed in NSCs of LCN2-null mice,
strengths this hypothesis.
Of interest, LCN2 has been extensively described in the brain to
be mainly expressed in response to injury or inﬂammation, so it
can engage critical roles in the progression and establishment of
inﬂammation.35 Particularly, others have shown LCN2 secretion by
astrocytes to target and modulate microglia activation and
polarization into M1 phenotype, and also to target astrocytes in
an autocrine fashion manner for pro-inﬂammatory activation.35
Interestingly, astroglial cells can sharply affect neurogenesis,
through the release of inﬂammatory cytokines, by regulating
progenitors proliferation, differentiation and the survival of new
adult-born neurons.36 Noticeably, LCN2 could, through this route,
and in case of neuroinﬂammation, impact on neurogenesis by
regulating progenitors proliferation and differentiation, and the
survival of new adult-born neurons. Still, herein, we believe that, in
physiological conditions, regulation of adult neurogenesis by
LCN2 may arise from the external systemic environment. While in
the physiological brain most reports are unanimous in not
detecting LCN2 expression,27,28,37 with the exception for a few
conﬂicting reports,24 LCN2 is described to be highly present in the
serum at physiological conditions,38 in accordance with our
current observations. As so, it is possible that regulation of adult
neurogenesis by LCN2 may occur through its delivery by the
blood vessels located within the niche and that surround neural
progenitors. Of notice, others have shown, particularly in aging,
that the systemic milieu and its circulating factors can regulate
neurogenesis and cognitive function.39 Future studies should
consider the potential role of the cells at the periphery that
produce LCN2 (for example, neutrophils, hepatocytes) in the
regulation of brain cell genesis, and even of the cells in the central
nervous system (for example, neurons, astrocytes), despite the
production of LCN2 in the brain, under basal conditions, being at
levels below detection with the current available methods.
Stem cells usually reside in an environment of reduced redox
status, which favours self-renewal and differentiation,40 high-
lighting the importance of a proper redox balance. In line with
this, and in case of oxidative stress, all cells have a complex
antioxidant system to detoxify endogenous ROS.41 The glu-
tathione peroxidase group of antioxidant enzymes acts in concert
to remove ROS and, among them, Gpx4 is considered the primary
enzymatic defence system against oxidative damage.41 In line
with this, we assessed the number of neural stem precursors
Sox2+ that expressed Gpx4. The fact that signiﬁcantly less Sox2+
cells in LCN2-null mice DG co-expressed Gpx4, along with the
in vitro data of increased intracellular levels of ROS in NSCs,
conﬁrms the inefﬁcient antioxidant regulatory system of LCN2-null
mice. This is, most likely, contributing to further impaired
hippocampal function in contextual fear conditioning tasks, as
the ultimate consequence of impaired cell differentiation. This
imbalanced redox regulation in LCN2-null mice, resultant of iron
trafﬁcking misregulation, can also be the critical mediator of
previous observed impairments in hippocampal plasticity and
animal behaviour.25 Speciﬁcally, we have previously shown that
LCN2-null mice display anxious- and depressive-like behaviours
and spatial learning impairments, along with an altered hippo-
campal neuronal cytoarchitecture and synaptic plasticity.25
Importantly, herein, we cannot exclude the limitation of a full
knockout system in disclosing important regulatory mechanisms
of adult neurogenesis. LCN2 is certainly not the only key mediator
of the process we here describe. The present data support that a
further understanding on whether LCN2 acts in a context- and
cellular-dependent manner, through the use of conditional-null
models, will provide clues on whether its modulation may impact
neurogenesis in health and in disease. Nevertheless, and in
summary, the present study provides the detailed sequence of
events for the role of LCN2 as a novel modulator of iron-mediated
oxidative stress in the orchestration of neurogenesis for hippo-
campal plasticity and behavioural function. As such, these ﬁndings
add an important piece into the current knowledge on the
mechanisms modulating adult mammalian neurogenesis.
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